Resources supporting trustworthy, rapid and equitable evidence synthesis and guideline development: results from the COVID-19 evidence network to support decision-making (COVID-END)

Michael McCaul¹, David Tovey², Taryn Young³, Vivian Welch⁴, Omar Dewidar⁵, Mireille Goetghebeur⁶, Tamara Kredo⁷, Andrea C Tricco⁸, Rebecca E Glover⁹, Janice Tufte¹⁰, Amir Qaseem¹¹, Reveiz Ludovic¹², Rebecca L Morgan¹³, Per Olav Vandvik¹⁴, Ivan D Florez¹⁵; COVID-END Recommending, Synthesizing and Equity Working Groups

Affiliations

¹ Centre for Evidence-based Health Care, Division of Epidemiology and Biostatistics, Department of Global Health, Stellenbosch University, Cape Town, South Africa. Electronic address: mmccaul@sun.ac.za.
² Member, COVID-END secretariat 2020-21, London, UK.
³ Centre for Evidence-based Health Care, Division of Epidemiology and Biostatistics, Department of Global Health, Stellenbosch University, Cape Town, South Africa.
⁴ School of Epidemiology and Public Health, University of Ottawa, 600 Peter Morand Crescent, Ottawa, Ontario, K1G 5Z3, Canada; Bruyère Research Institute, University of Ottawa, 85 Primrose Ave, Ottawa, Ontario, K1R 6M1, Canada.
⁵ Bruyère Research Institute, University of Ottawa, 85 Primrose Ave, Ottawa, Ontario, K1R 6M1, Canada.
⁶ Bureau Methods and Ethics, Institut National d'Excellence en Santé et Services Sociaux, Montreal, Québec, Canada; Department of Evaluation and Health Policy, School of Public Health, University of Montreal, Montreal, Quebec, Canada.
⁷ Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa; Division of Clinical Pharmacology, Department of Medicine, Stellenbosch University, Cape Town, South Africa.
⁸ Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, Canada; Epidemiology Division and Institute of Health Policy, Management, and Evaluation, Dalla Lana School of Public Health, University of Toronto, Canada; Queen's Collaboration for Health Care Quality Joanna Briggs Institute Centre of Excellence, Queen's University, Kingston, Canada.
⁹ Department of Health Services Research and Policy, Faculty of Public Health and Policy, LSHTM, London, United Kingdom.
¹⁰ Cochrane Consumer, Seattle, Washington, USA.
¹¹ American College of Physicians, Philadelphia, Pennsylvania, USA.
¹² Knowledge Translation Program, Evidence and Intelligence for Action in Health Department, Pan American Health Organization, Washington DC, USA.
¹³ Department of Health Research, Evidence and Impact, McMaster University, Hamilton, Canada.
¹⁴ Department of Medicine, Lovisenberg Diaconal Hospital, Oslo, Norway.
¹⁵ Department of Pediatrics and Childcare, Universidad de Antioquia, Medellín, Colombia; School of Rehabilitation Science, McMaster University, Hamilton, Canada; Pediatric Intensive Care Unit, Clinica Las Americas-AUNA, Dg. 75B #2A-80/140, Medellin, Colombia.

PMID: 35868494
PMCID: PMC9295316
DOI: 10.1016/j.jclinepi.2022.07.008

Resources supporting trustworthy, rapid and equitable evidence synthesis and guideline development: results from the COVID-19 evidence network to support decision-making (COVID-END)

Michael McCaul et al. J Clin Epidemiol. 2022 Nov.

. 2022 Nov:151:88-95.

doi: 10.1016/j.jclinepi.2022.07.008. Epub 2022 Jul 19.

Authors

Affiliations

¹ Centre for Evidence-based Health Care, Division of Epidemiology and Biostatistics, Department of Global Health, Stellenbosch University, Cape Town, South Africa. Electronic address: mmccaul@sun.ac.za.
² Member, COVID-END secretariat 2020-21, London, UK.
³ Centre for Evidence-based Health Care, Division of Epidemiology and Biostatistics, Department of Global Health, Stellenbosch University, Cape Town, South Africa.
⁴ School of Epidemiology and Public Health, University of Ottawa, 600 Peter Morand Crescent, Ottawa, Ontario, K1G 5Z3, Canada; Bruyère Research Institute, University of Ottawa, 85 Primrose Ave, Ottawa, Ontario, K1R 6M1, Canada.
⁵ Bruyère Research Institute, University of Ottawa, 85 Primrose Ave, Ottawa, Ontario, K1R 6M1, Canada.
⁶ Bureau Methods and Ethics, Institut National d'Excellence en Santé et Services Sociaux, Montreal, Québec, Canada; Department of Evaluation and Health Policy, School of Public Health, University of Montreal, Montreal, Quebec, Canada.
⁷ Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa; Division of Clinical Pharmacology, Department of Medicine, Stellenbosch University, Cape Town, South Africa.
⁸ Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, Canada; Epidemiology Division and Institute of Health Policy, Management, and Evaluation, Dalla Lana School of Public Health, University of Toronto, Canada; Queen's Collaboration for Health Care Quality Joanna Briggs Institute Centre of Excellence, Queen's University, Kingston, Canada.
⁹ Department of Health Services Research and Policy, Faculty of Public Health and Policy, LSHTM, London, United Kingdom.
¹⁰ Cochrane Consumer, Seattle, Washington, USA.
¹¹ American College of Physicians, Philadelphia, Pennsylvania, USA.
¹² Knowledge Translation Program, Evidence and Intelligence for Action in Health Department, Pan American Health Organization, Washington DC, USA.
¹³ Department of Health Research, Evidence and Impact, McMaster University, Hamilton, Canada.
¹⁴ Department of Medicine, Lovisenberg Diaconal Hospital, Oslo, Norway.
¹⁵ Department of Pediatrics and Childcare, Universidad de Antioquia, Medellín, Colombia; School of Rehabilitation Science, McMaster University, Hamilton, Canada; Pediatric Intensive Care Unit, Clinica Las Americas-AUNA, Dg. 75B #2A-80/140, Medellin, Colombia.

PMID: 35868494
PMCID: PMC9295316
DOI: 10.1016/j.jclinepi.2022.07.008

No abstract available

PubMed Disclaimer

Figures

**Fig. 1**
COVID-END evidence synthesis and systematic resource flow diagram.

**Fig. 2**
COVID-END Guideline and HTA flow diagram.

See this image and copyright information in PMC

Comment in

November 2022 Editor's choice.
Tugwell P, Tovey D. Tugwell P, et al. J Clin Epidemiol. 2022 Nov;151:A1-A2. doi: 10.1016/j.jclinepi.2022.11.013. J Clin Epidemiol. 2022. PMID: 36526340 Free PMC article. No abstract available.

References

1. Ioannidis J.P.A., Salholz-Hillel M., Boyack K.W., Baas J. The rapid, massive growth of COVID-19 authors in the scientific literature. R Soc Open Sci. 2021;8(9) doi: 10.1098/rsos.210389. - DOI - PMC - PubMed
1. Naeem S Bin, Bhatti R. The Covid-19 ‘infodemic’: a new front for information professionals. Heal Inf Libr J. 2020;37(3):233–239. - PMC - PubMed
1. Jung R.G., Di Santo P., Clifford C., Prosperi-Porta G., Skanes S., Hung A., et al. Methodological quality of COVID-19 clinical research. Nat Commun. 2021;12(1):1–10. - PMC - PubMed
1. Akl E.A., Morgan R.L., Rooney A.A., Beverly B., Vittal Katikireddi S., Agarwal A., et al. Developing trustworthy recommendations as part of an urgent response (1–2 weeks): a GRADE concept paper. J Clin Epidemiol. 2021;129:1–11. - PMC - PubMed
1. Tricco A.C., Garritty C.M., Boulos L., Lockwood C., Wilson M., McGowan J., et al. Rapid review methods more challenging during COVID-19: commentary with a focus on 8 knowledge synthesis steps. J Clin Epidemiol. 2020;126:177–183. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Resources supporting trustworthy, rapid and equitable evidence synthesis and guideline development: results from the COVID-19 evidence network to support decision-making (COVID-END)

Affiliations

Resources supporting trustworthy, rapid and equitable evidence synthesis and guideline development: results from the COVID-19 evidence network to support decision-making (COVID-END)

Authors

Affiliations

Figures

Comment in

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical